» Articles » PMID: 17932103

Combined Effects of Obesity, Acid Reflux and Smoking on the Risk of Adenocarcinomas of the Oesophagus

Overview
Journal Gut
Specialty Gastroenterology
Date 2007 Oct 13
PMID 17932103
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To measure the relative risks of adenocarcinomas of the oesophagus and gastro-oesophageal junction associated with measures of obesity, and their interactions with age, sex, gastro-oesophageal reflux symptoms and smoking.

Design And Setting: Population-based case-control study in Australia.

Patients: Patients with adenocarcinomas of the oesophagus (n = 367) or gastro-oesophageal junction (n = 426) were compared with control participants (n = 1580) sampled from a population register.

Main Outcome Measure: Relative risk of adenocarcinoma of the oesophagus or gastro-oesophageal junction.

Results: Risks of oesophageal adenocarcinoma increased monotonically with body mass index (BMI) (p(trend) <0.001). Highest risks were seen for BMI >or=40 kg/m2 (odds ratio (OR) = 6.1, 95% CI 2.7 to 13.6) compared with "healthy" BMI (18.5-24.9 kg/m2). Adjustment for gastro-oesophageal reflux and other factors modestly attenuated risks. Risks associated with obesity were substantially higher among men (OR = 2.6, 95% CI 1.8 to 3.9) than women (OR = 1.4, 95% CI 0.5 to 3.5), and among those aged <50 years (OR = 7.5, 95% CI 1.7 to 33.0) than those aged >or=50 years (OR = 2.2, 95% CI 1.5 to 3.1). Obese people with frequent symptoms of gastro-oesophageal reflux had significantly higher risks (OR = 16.5, 95% CI 8.9 to 30.6) than people with obesity but no reflux (OR = 2.2, 95% CI 1.1 to 4.3) or reflux but no obesity (OR = 5.6, 95% 2.8 to 11.3), consistent with a synergistic interaction between these factors. Similar associations, but of smaller magnitude, were seen for gastro-oesophageal junction adenocarcinomas.

Conclusions: Obesity increases the risk of oesophageal adenocarcinoma independently of other factors, particularly among men. From a clinical perspective, these data suggest that patients with obesity and frequent symptoms of gastro-oesophageal reflux are at especially increased risk of adenocarcinoma.

Citing Articles

Chemotherapy effects on mitochondrial function in adipose tissue in oesophageal and gastroesophageal junction adenocarcinomas with or without associated cachexia: protocol for a prospective, comparative observational study (ChiFMeOE).

Bacoeur-Ouzillou O, Guerrier L, Touron J, Pinel A, Pereira B, Meunier N BMJ Open. 2024; 14(10):e086686.

PMID: 39448207 PMC: 11499755. DOI: 10.1136/bmjopen-2024-086686.


Bibliometric and visual analysis of esophagogastric junction cancer research from 2002 to 2021.

Wang Z, Li X, Hu J, Guo X, Gao B, Zhu B Medicine (Baltimore). 2024; 103(20):e38100.

PMID: 38758908 PMC: 11098202. DOI: 10.1097/MD.0000000000038100.


Molecular Biology and Clinical Management of Esophageal Adenocarcinoma.

Li S, Hoefnagel S, Krishnadath K Cancers (Basel). 2023; 15(22).

PMID: 38001670 PMC: 10670638. DOI: 10.3390/cancers15225410.


Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma.

Agarwal S, Bell M, Dhaliwal L, Codipilly D, Dierkhising R, Lansing R Dig Dis Sci. 2023; 69(1):246-253.

PMID: 37914889 PMC: 10926253. DOI: 10.1007/s10620-023-08126-6.


Sleep Behaviors, Genetic Predispositions, and Risk of Esophageal Cancer.

Wang X, Tian R, Zong X, Jeon M, Luo J, Colditz G Cancer Epidemiol Biomarkers Prev. 2023; 32(8):1079-1086.

PMID: 37195052 PMC: 10525008. DOI: 10.1158/1055-9965.EPI-23-0101.